-
LifeSci Capital's Andrew McDonald On How To Invest In Booming Biotech
Friday, April 17, 2015 - 2:56pm | 1016Read More..."Biotech is booming," says LifeSci Capital co-founder and co-manager of the BioShares exchange traded funds, Andrew McDonald. McDonald, along with fellow LifeSci co-founder Paul Yook, spoke with Benzinga about innovations in biotech and how investors might take advantage. BZ: What...
-
Piper Jaffray Remains Neutral On ALNY In Advance Of ASCO Meeting
Thursday, May 19, 2011 - 7:57am | 92Read More...Piper Jaffray is maintaining its Neutral rating and its $10 price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) as the company prepares to report at ASCO on June 4th. In the report, Piper Jaffray writes, “Abstracts were published last night for the upcoming American Society of Clinical Oncology...
